AN IN-SITU MAGNESIUM HYDROXIDE NANOSHEET LAYER MODIFIED MAGNESIUM ALLOY AND PREPARATION AND APPLICATION THEREOF
20220090236 · 2022-03-24
Inventors
- Guomin WANG (Shenzhen, Guangdong, CN)
- Huaiyu WANG (Shenzhen, Guangdong, CN)
- Kimho Paul CHU (Shenzhen, Guangdong, CN)
Cpc classification
B82Y5/00
PERFORMING OPERATIONS; TRANSPORTING
C23C22/60
CHEMISTRY; METALLURGY
A61L27/50
HUMAN NECESSITIES
A61L2400/18
HUMAN NECESSITIES
A61L2400/12
HUMAN NECESSITIES
A61L2300/102
HUMAN NECESSITIES
A61L27/306
HUMAN NECESSITIES
A61L27/047
HUMAN NECESSITIES
A61L27/54
HUMAN NECESSITIES
International classification
A61L27/54
HUMAN NECESSITIES
Abstract
The present invention relates to a magnesium alloy material, which is an in situ magnesium hydroxide nanosheet layer modified magnesium alloy. The material is prepared from a magnesium alloy through a hydrothermal reaction under alkaline condition. The protective effect of the in situ formed magnesium hydroxide nanosheet layer structure results in remarkably enhanced corrosion resistance of the magnesium alloy, meanwhile the biocompatibility can also be significantly improved since the release rate of magnesium ion can be significantly reduced. In addition, the two-dimensional nanolayer structure has a non-releasing physical antibacterial property depending on contact. Therefore, the magnesium alloy material according to the present invention has an extremely great application prospect in the field of medical implant.
Claims
1. A magnesium alloy material, wherein it comprises a magnesium alloy body and a magnesium hydroxide nanosheet layer on the surface; the magnesium hydroxide nanosheet in the magnesium hydroxide nanosheet layer has an area between 1 nm2 and 10 μm2 and a thickness between 1 nm and 2 μm.
2. The magnesium alloy material according to claim 1, wherein the magnesium hydroxide nanosheet has an area between 50 nm2 and 5 μm2 and a thickness between 5 nm and 1 μm.
3. The magnesium alloy material according to claim 1, wherein the magnesium alloy body is a magnesium alloy having a magnesium content greater than 85%; preferably a magnesium content greater than 90%; and most preferably greater than 92%.
4. A preparation method of a magnesium alloy material, wherein it comprises the step of conducting a hydrothermal reaction of a magnesium alloy under an alkaline condition to form a magnesium hydroxide nanosheet layer in situ.
5. The preparation method according to claim 4, wherein the temperature of the hydrothermal reaction is from 60 to 200° C.; and the reaction time is more than 30 minutes.
6. The preparation method according to claim 5, wherein the temperature of the hydrothermal reaction is preferably from 80 to 180° C., most preferably from 90 to 160° C.; the reaction time is preferably more than 2 hours; most preferably between 4 and 72 hours.
7. The preparation method according to claim 4, wherein the heating rate is 1-30° C. min−1; preferably 2-20° C. min−1.
8. The preparation method according to claim 4, wherein the alkaline condition refers to a pH value between 8 and 14, and preferably between 8 and 12.
9. The preparation method according to claim 8, wherein the pH value of the hydrothermal reaction is controlled using an aqueous solution of sodium hydroxide, potassium hydroxide, calcium hydroxide, barium hydroxide or aqueous ammonia.
10. Method of applying the magnesium alloy material according to claim 1, comprising the step of applying the magnesium alloy material as a medical implant.
11. Method of applying the magnesium alloy material according to claim 2, comprising the step of applying the magnesium alloy material as a medical implant.
12. Method of applying the magnesium alloy material according to claim 3, comprising the step of applying the magnesium alloy material as a medical implant.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
DETAILED DESCRIPTION OF THE EMBODIMENTS
Example 1
[0059] Magnesium sheets with a length×width×height of 10 mm×10 mm×5 mm were polished and grinded, and washed well with alcohol. The samples were placed into a reaction kettle with a volume of 25 mL, and 10 mL of aqueous sodium hydroxide solution of pH=12 was added. The reaction kettle was screwed and placed in a muffle furnace, wherein the heating rate was 10° C. min.sup.−1, the reaction temperature was 120° C., and the reaction time was 4 h, 8 h and 12 h. After the reaction was completed, the micromorphologies of various samples were observed by scanning electron microscope respectively. As can be seen in
Example 2
[0060] The surfaces of the samples obtained by the treatment of Example 1 were subjected to crystallography and chemical element analysis. The results from high resolution TEM (
Example 3
[0061] The corrosion resistance property of the samples was analyzed by an immersion method and an electrochemical analysis method. After immersion of the untreated magnesium block, there were many cracks on the surface, but the surface of the magnesium alloy modified by the magnesium hydroxide sheet layer had no change in structure (
Example 4
[0062] The samples obtained in Example 1 were sterilized and osteoblasts were cultured on the surface. The proliferation of the cells was examined by MTT. The results showed that the cell proliferation with HT12 was more evident (
Example 5
[0063] The samples obtained in Example 1 were used in the antibacterial (Staphylococcus aureus and Escherichia coli) test. The antibacterial effect was evaluated by the spread plate and count method, and the results were shown in
Example 6
[0064] By increasing the volume of the antibacterial system to 1 mL, it was found that the antibacterial effect of HT12 decreased significantly and the group of magnesium block did not change significantly (
Example 7
[0065] The samples of Example 1 were implanted into the subcutaneous tissues of mice as implants, and the untreated magnesium blocks and titanium blocks were used as the control groups. The wounds were carefully sutured after implantation. The implants were taken out on the 3rd, 7th, 10th, and 14th days to detect the bacterial contents at the implant and at surrounding tissues by the spread plate and count method. At the same time, the tissues surrounding the implants were fixed and sliced for H&E staining to verify the effect. The results showed that HT12 can effectively kill the bacteria at the implants and at their surrounding environment. In addition, the inflammatory response of the tissue in the HT12 group was weaker compared with the two control groups (